Charles River Acquires Retrogenix This acquisition will offer clients an integrated, end-to-end solution for therapeutic antibody and cell and gene therapy discovery and development. learn more Research Models & Services Discovery Services Safety Assessment Laboratory Sciences Biologics Testing Solutions QC Microbial Solutions Featured Story Advancing Preclinical Oncology Studies with Novel Implantable Microdevices Learn More Vital Science S2, E07: In Vitro 3D Models: A Blueprint for Drug Development tool Cancer Model Database Insights Featured Story Is Your Cell and Gene Therapy Manufacturing at Risk for SARS-CoV-2? Learn More blog E34: Drug Approval in the New Normal Learn More Featured Story Could In-House Breeding Be Compromising Your Research? Learn More blog The Hunt for a COVID Vaccine: How Scientists Advanced their Target Learn More View All
